APA (7th ed.) Citation

Petrou, P., Gothelf, Y., Argov, Z., Gotkine, M., Levy, Y. S., Kassis, I., . . . Karussis, D. (2016). Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. JAMA neurology, 73(3), 337. https://doi.org/10.1001/jamaneurol.2015.4321

Chicago Style (17th ed.) Citation

Petrou, Panayiota, et al. "Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials." JAMA Neurology 73, no. 3 (2016): 337. https://doi.org/10.1001/jamaneurol.2015.4321.

MLA (9th ed.) Citation

Petrou, Panayiota, et al. "Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials." JAMA Neurology, vol. 73, no. 3, 2016, p. 337, https://doi.org/10.1001/jamaneurol.2015.4321.